Back to Trades
Cravatt Benjamin
DirectorCIK 0001819573
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Cravatt Benjamin, Director, has disclosed $1.3M in transactions — all concentrated in ALNYLAM PHARMACEUTICALS, INC. (ALNY). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jun 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Cravatt Benjamin | Director | Award | $1.3M |
| Jun 3 | ALNY ALNYLAM PHARMACEUTICALS, INC. | Cravatt Benjamin | Director | Other | $0 |
2 filings